This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
Erie Indemnity (ERIE) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of -5.92% and -2.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ERIENegative Net Change FUFUPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Live Nation (LYV) Misses Q2 Earnings Estimates
by Zacks Equity Research
Live Nation (LYV) delivered earnings and revenue surprises of -59.41% and +3.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LYVPositive Net Change SNALPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nektar (NKTR) delivered earnings and revenue surprises of +5.75% and +3.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NKTRPositive Net Change MDWDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Rapid7 (RPD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Rapid7 (RPD) delivered earnings and revenue surprises of +31.82% and +1.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RPDNegative Net Change IOTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AudioEye (AEYE) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
AudioEye (AEYE) delivered earnings and revenue surprises of -6.25% and -0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AEYEPositive Net Change CINTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DOCSNegative Net Change LABNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gen Digital (GEN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital (GEN) delivered earnings and revenue surprises of +6.67% and +6.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GENNegative Net Change QXONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Akamai Technologies (AKAM) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Akamai Technologies (AKAM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AKAMPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMPHPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Monster Beverage (MNST) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Monster Beverage (MNST) delivered earnings and revenue surprises of +8.33% and +1.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MNSTNegative Net Change HAINNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Nerdy (NRDY) delivered earnings and revenue surprises of +30.00% and -3.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NRDYNegative Net Change LINCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +22.43% and +4.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PTCTPositive Net Change XOMAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Solventum (SOLV) delivered earnings and revenue surprises of +16.55% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SOLVNegative Net Change PACSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Turtle Beach (TBCH) delivered earnings and revenue surprises of +48.15% and -0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TBCHNegative Net Change LFWDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Consensus Cloud Solutions, Inc. (CCSI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Consensus Cloud Solutions (CCSI) delivered earnings and revenue surprises of +7.35% and +1.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CCSINegative Net Change BASENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2
by Zacks Equity Research
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +100.00% and +2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CTMXPositive Net Change OCSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
EOG Resources (EOG) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
EOG Resources (EOG) delivered earnings and revenue surprises of +4.98% and +0.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EOGPositive Net Change NFEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HireQuest, Inc. (HQI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
HireQuest (HQI) delivered earnings and revenue surprises of +36.36% and +1.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HQINegative Net Change DSPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Maplebear (CART) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Maplebear (CART) delivered earnings and revenue surprises of +5.13% and +2.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CARTNegative Net Change PSQHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Dianthus Therapeutics, Inc. (DNTH) delivered earnings and revenue surprises of -2.33% and -84.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DNTHPositive Net Change CVACNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
GigaCloud Technology Inc. (GCT) delivered earnings and revenue surprises of +97.83% and +11.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GCTNegative Net Change BTBTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
GoDaddy (GDDY) delivered earnings and revenue surprises of +5.22% and +1.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GDDYNegative Net Change VRNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Akamai Technologies (AKAM) delivered earnings and revenue surprises of +11.61% and +2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AKAMPositive Net Change LPSNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Biodesix (BDSX) delivered earnings and revenue surprises of -14.29% and +7.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BDSXPositive Net Change HQYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
by Zacks Equity Research
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +100.00% and +6.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BLFSPositive Net Change ALURNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank